Manufacturing Management Software Platform Uses Integrated Modules
A new version of Parsec’s modular manufacturing management software, TrakSYS, is a web-based platform with modules that can be deployed for specific tasks or as a full manufacturing execution system.
Image courtesy of Parsec
The latest version of Parsec’s modular manufacturing management software, TrakSYS, is a web-based platform with multiple, fully-integrated modules that can be used as a full manufacturing execution system (MES) or deployed to solve one or more business challenges, such as overall equipment effectiveness, statistical process control, e-records, maintenance, traceability, workflow, batch processing, sustainability, labor, and others. In the new, flexible version, manufacturers can turn on specific features at any time and customize a solution that specifically addresses their needs.
The software provides a real-time view of manufacturing operations and allows a deeper understanding of trends and patterns to drive efficiency. The cost-effective software simplifies the manufacturing management process and is built to be deployed quickly with out-of-the-box functionality.
Source: Parsec
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
